Life Recharged: A Transformative Journey with Stem Cell Therapy and Regenerative Medicine

The founder of GSD Venture Studios recently experienced a special journey at Revival Clinic Bangkok, where they had a second stem cell treatment that restored their health and opened the possibility of regenerative medicine, which is an improved factor in this health. This experience is proof of the great impact of the newest science in transforming people and their capabilities, and it’s changing our world completely.

The outcomes were tiredness from weeks-long commutes, constant jet lag, and the psycho-emotional toll of relentless pressure, resulting in energy deficiency, bodily pain, and a visible slump in vitality. The well-known treatment methods were short-term palliative drugs and patches that only relieved the symptoms, not the cause. These inefficient and temporary Band-Aid solutions impeded the search for real healing at the Revival Clinic Bangkok, the leading worldwide regenerative medicine center.

Revival Clinic Bangkok is a medical institution specializing in revolutionary age-reversal therapies such as MSC therapy, NAD therapy, and revitalization programs fitted to each individual’s body to regain and ameliorate natural functions. The selection of the second stele cell treatment itself was a breakthrough moment that would correspondingly redirect the concept of health, age, and even modern medical discoveries.

With the expertise of Dr. George, who was trained at MIT and specializes in regenerative medicine, the clinic is driven by science and tailor-made care derived from credible sources of information. Revival Clinic provides highly individualized treatment plans to ensure precise and innovative treatment, thus ensuring the desired results.

The main goal of the transformation trip was the second round of Mesenchymal Stem Cell (MSC) therapy. Mesenchymal stem cells are usually derived from ethically obtained umbilical cord tissue and are normally known for their anti-inflammatory and repair mechanism of damaged tissues and rejuvenating aging tissues. Awaiting the potential outcomes, as the IV infusion was introducing millions of regenerative cells into the body.

The results were nothing short of remarkable. Within days, noticeable changes began to emerge:

– Energy Surge: A renewed sense of vitality replaced the persistent fatigue that had become a constant companion.

– Mental Clarity: Brain fog lifted, replaced by sharp focus and enhanced cognitive function.

– Pain Relief: Muscles felt lighter and stronger, free from the chronic aches that had hindered daily life.

– Vitality Boost: The overall sensation was akin to a factory reset as if the body had been restored to its peak condition.

The treatment positively affected Dr. Gary Selby Milam and other patients and was the turning point in their lives. The cases where sciatica, kidney disease, and chronic pain were the causes of illness were the examples that were given to show that the height of stem cell therapy was noticed on the way to the patient’s health. The use of MSC therapy in the treatment of various health problems presented a new era of medicinal treatment that has the potential to heal a number of disorders.

They have an array of the latest methods in anti-aging and long-life programs. NAD therapy, cerebrolysin, and placenta plasma therapy were some of the therapies that worked alongside MSC treatment.

NAD (Nicotinamide Adenine Dinucleotide) is a pivotal coenzyme that supports cell function. However, the NAD level decreases with age, resulting in low energy, cognitive loss, and delayed cellular repair. The NAD IV infusion done at Revival Clinic was indeed a cellular charger, as it delivered a rapid boost of stamina and mental sharpness that was also immediate and profound.

Cognitive performance is very important for people who work in high-pressure situations. Cerebrolysin, a neuropeptide treatment, greatly enhances the brain’s functioning by nerve cell generation and synaptic plasticity. As a result, the lack of focus was replaced with increased creativity and thought and sustained mental stamina, which are basic tools for success at work and home.

Placenta Plasma Therapy, though lesser known, is a potent treatment that utilizes growth factors to rejuvenate cells and skin. Post-treatment, visible skin texture, and complexion improvements were evident, offering a tangible reminder of the body’s renewed vitality.

This journey through regenerative medicine has redefined the narrative around aging and healthcare. Longevity is no longer about merely adding years to life but enhancing the quality of those years. The benefits experienced—increased stamina, razor-sharp cognition, freedom from chronic pain, and youthful vibrancy—underscore the potential of regenerative medicine to transform lives.

Perhaps the most profound outcome was the rekindling of purpose and optimism. Regenerative medicine is not a distant dream; it is a reality that is rewriting the rules of what is possible in health and wellness.

For those grappling with fatigue, aging, or chronic health challenges, the message is clear: do not settle for temporary fixes. The potential to reclaim vitality and restore well-being through regenerative medicine is real and within reach. Revival Clinic Bangkok, committed to ethical science and personalized care, is a leading destination for those ready to take the first step toward a healthier, more vibrant future.

About GSD Venture Studios:

GSD Venture Studios is a venture-building platform dedicated to fostering innovation and driving transformative change across industries. Through its commitment to cutting-edge technologies and forward-thinking solutions, GSD Venture Studios continues to push the boundaries of what is possible.

About Revival Clinic Bangkok:

Revival Clinic Bangkok is a global leader in regenerative medicine, offering advanced therapies such as stem cell treatment, NAD therapy, and neurodegenerative treatments. With a focus on personalized care and evidence-based science, the clinic is at the forefront of longevity and wellness innovation.

Media Contact
Company Name: GSD Venture Studios, LLC
Contact Person: Gary Fowler
Email: Send Email
Country: United States
Website: http://www.gsdvs.com

Valerann has been Awarded a €3.6M Contract by the European Space Agency to Develop a Road Traffic Monitoring Platform using AI and Satellite Data

Valerann has been Awarded a €3.6M Contract by the European Space Agency to Develop a Road Traffic Monitoring Platform using AI and Satellite Data
Valerann, a global leader in AI-powered, data-driven road traffic management solutions, has been awarded a €3.6M co-funded contract from the European Space Agency’s Business Applications and Space Solutions (BASS) program.

Valerann, a global leader in AI-powered, data-driven road traffic management solutions, has been awarded a €3.6M co-funded contract from the European Space Agency’s Business Applications and Space Solutions (BASS) program. The contract will support the development and demonstration of an AI and satellite data-enabled traffic monitoring and incident detection platform designed to enhance nationwide road network safety and efficiency. The initiative aligns with the BASS program’s objective of supporting innovative services that leverage space technology and data in key markets, such as transportation. It is also aligned with the EU Global Gateway Strategy’s aims for seamless, sustainable, and environmentally friendly international corridor management.

Proven through deployments with leading public and private road traffic authorities—Lanternn by Valeran (LbV), Valerann’s flagship product, helps road operators improve road safety. The advanced data analytics platform uses deep data fusion to process very large volumes of current and historical traffic-related data to instantly deliver a holistic, real-time overview of single corridor road traffic, including risk profiling, on a single pane of glass. It enables road traffic authorities in Europe, the US, Central and Latin Americas to adopt a proactive road traffic management approach while achieving a double percentage reduction in serious traffic accidents.

Building on the success of LbV, the new transformational system, Lanternn by Valerann for networks, will feature crucial capabilities for managing national-scale road networks, arterial roads and intersections. These include superior holistic coverage of traffic and road assets monitoring, risk management, improvement of incident management and prioritization, while extending real-time traffic monitoring and predictive capabilities to underserved rural roads which often lack advanced monitoring systems. Satellite positioning information derived from mobile and vehicle navigation applications will play a key role in enabling these capabilities.

LbV for networks aggregates data from various sources, including street side sensors, third-party datasets, and GNSS (Global Navigation Satellite System) derived mobility data transforming this information into an enriched, unified dataset to ensure a cohesive view of traffic flow across complex networks, including urban and suburban roads, beyond the simplicity of a single road corridor.

Additionally, by leveraging GNSS data from fleets, LbV for networks enables real-time monitoring of emergency vehicles, patrol units, snow ploughs, and other operational assets, allowing national and municipal operators to improve response coordination and optimize road maintenance. Satellite-enabled weather alerts will inform operators of dangerous weather events such as hailstorms and ice risks, allowing for proactive planning and intervention.

Investing in real-time traffic monitoring for both rural areas and motorways is equally important, as it can significantly improve safety, efficiency, and emergency response.

“This funding from ESA marks a significant milestone in our mission to transform road traffic safety and efficiency,” – says Michael Vardi, CBO and co-founder of Valerann. “By extending our monitoring capabilities to large, complex road networks and rural areas, we aim to further reduce accidents and improve response times, ultimately saving lives.”

“ESA Space Solutions is pleased to support Valerann in leveraging satellite data and AI to improve safety on our roads. Developing the capability to cover national-scale and rural networks has the potential to further support accident prevention and improve overall traffic management.” – Christopher Frost-Tesfaye, Space Applications Officer at European Space Agency.

‍About ESA Space Solutions

ESA Space Solutions helps businesses from all corners of Europe to harness space technology to improve life on Earth. We work side by side with industry, developing space-enabled solutions that will grow your business and bring essential socioeconomic benefits. All our activities have a focus on the green transition and the global shift towards a more digital, sustainable future.

For more information, please visit us at: https://business.esa.int.

About Valerann

Valerann, global leader in advanced road traffic management solutions (ATMS), is redefining the concept of modern mobility through increasing roadway safety and improving operational efficiency. Our industry leading cloud platform Lanternn by Valerann improves road traffic authorities’ situational awareness, provides with road traffic situation insights, including risk profiling, and significantly reduces incident detection time. By leveraging sophisticated proprietary AI and computer vision algorithms we process large volumes of real-time traffic-related data and enable road traffic authorities to take accurate, actionable, and timely decisions. Our multi-award-winning solution is used by public and private operators in the US, UK, Europe and in Central and Latin America. Our customers report double-digit reduction in accidents rate as a result of proactive road management. Established in 2016, Valerann has offices in the UK, the US, Israel and Spain serving customers world-wide.

Media Contact
Company Name: Valerann
Contact Person: Media Relations
Email: Send Email
Country: United Kingdom
Website: https://www.valerann.com/

Nicolet Law Accident & Injury Lawyers Engages in Community and Legal Advocacy

Nicolet Law Accident & Injury Lawyers supports communities through sponsorships, scholarships, and legal advocacy, ensuring access to justice for injury victims.

Minneapolis, MN – March 19, 2025 – Nicolet Law Accident & Injury Lawyers operates in the Midwest, participating in community initiatives through sponsorships and charitable contributions. The firm supports regional music festivals, organizes a biannual scholarship program, and contributes to organizations such as the Feed My People Food Bank. These efforts reflect its involvement in local programs and outreach.

Nicolet Law Accident and Injury Lawyers Photo

In addition to community engagement, the firm provides legal services for individuals involved in personal injury cases. It primarily works with those affected by accidents, particularly where negligence is a factor. Nicolet Law offers free consultations, allowing individuals to receive information about their legal options without financial obligation.

Nicolet Law operates on a contingency fee basis, meaning clients are not required to pay legal fees unless compensation is secured on their behalf. This structure provides access to legal representation for individuals who may not have the means to pay upfront costs. By linking legal fees to case outcomes, this approach aligns legal services with client recovery efforts.

The legal team at Nicolet Law manages various personal injury cases, handling legal procedures and case complexities on behalf of clients. The firm works with individuals navigating the legal process after an accident, assisting them in pursuing financial recovery. By providing legal representation, it aims to support clients in addressing the challenges associated with personal injury claims.

Future Plans

Nicolet Law plans to continue its involvement in community initiatives and legal advocacy. The firm is working to refine its processes and expand its services to additional communities while maintaining its approach to client representation.

DISCLAIMER: This press release is for informational purposes only. It does not constitute professional advice, nor should it be relied upon for any decision-making. While the information herein is believed to be accurate, it is not guaranteed. Nicolet Law and associated parties are not liable for any inaccuracies. Any actions taken based on this press release are at the reader’s discretion.

Purpose of the Press Release

This press release informs the public about Nicolet Law Accident & Injury Lawyers’ participation in community initiatives and its approach to handling personal injury cases. It highlights the firm’s involvement in regional events, scholarship programs, charitable causes, and its contingency fee structure, allowing individuals to seek legal assistance without upfront costs. Additionally, it outlines how the firm manages personal injury cases and its plans for future service expansion. The release provides relevant details for those in the Midwest seeking legal resources or interested in the firm’s community engagement efforts.

About Nicolet Law Accident & Injury Lawyers

Nicolet Law is a respected personal injury law firm. Committed to standing up for the rights of injured individuals, Nicolet Law has built a reputation for fierce advocacy and personalized client care. The firm focuses on cases involving car accidents, truck accidents, bike accidents, dog bites, wrongful deaths, motorcycle accidents, and other personal injury cases, offering services in English and Spanish. For more information about Nicolet Law Office and its team, please visit: Award-Winning Wisconsin, Iowa, North Dakota, and Minnesota Injury Lawyers | Nicolet Law

Media Contact
Company Name: Nicolet Law Accident and Injury Lawyers
Contact Person: Katie Paulson
Email: Send Email
Phone: (715) 377-2141
Country: United States
Website: https://nicoletlaw.com/

Julie Gentili from Mediation Northwest is Presenting at the Incorporating Technology and AI Into Your Divorce Mediation Practice: A Mediate.com Online Conference.

Julie Gentili from Mediation Northwest is Presenting at the Incorporating Technology and AI Into Your Divorce Mediation Practice: A Mediate.com Online Conference.
Guests will learn how to implement AI technology into their divorce mediation practices for more efficient processes

EUGENE, OREGON – MARCH 19, 2025 – Julie Gentili from Mediation Northwest will be presenting at Incorporating Technology and AI Into Your Divorce Mediation Practice: A Mediate.com Online Conference on March 19-20, 2025. This exclusive online conference will empower divorce mediation practices with critical information for effectively implementing technology and artificial intelligence to yield efficiency and greater client outcomes.

Mediation Northwest offers divorce mediation, post-divorce mediation, parenting time coordination, prenuptial agreement mediation, and post-marital agreement mediation services for its clients. To begin a mediation, a client gets started by setting up a phone consultation with attorney Julie Gentili. Then, the spouse connects with Mediation Northwest, and once this conversation has been conducted, a 2-hour Zoom mediation appointment is scheduled. Mediation Northwest uses various forms of technology, including AI, in its practice and has benefited from greater efficiency. Now, the practice is sharing these strategies with other mediation practices.

On day two of Incorporating Technology and AI Into Your Divorce Mediation Practice, Julie Gentili will present on how to draft a mediation settlement agreement (MSA) using document automation and Text Expander. The conference will walk guests through a template of a traditional divorce mediation from beginning to end using tools from leading software platforms.

The case scenario will be a divorce case with children, assets, and ethical concerns involved. Guests will begin with training and marketing seminars before diving into reticent parties, how to negotiate sticking points, drafting a MSA, finalizing forms, and more. The conference will be hosted online live, but it will be recorded and accessible for one year. Participants will be eligible for 6 CLEs/CEUs when they attend.

“In the world of mediation, we find that tedious, monotonous tasks tend to be time consuming and draining to our overall resources,” said Gentili. “Across the board, we’ve taken a close look at tasks that could be taken care of with technology, which would then free up time and resources for our practice. The Incorporating Technology and AI Into Your Divorce Mediation Practice conference will share all of this crucial information with guests, and we’re thrilled to be presenting.”

Registration for Incorporating Technology and AI Into Your Divorce Mediation Practice is now open online.

Gentili, a longtime attorney-mediator who excels at closing equitable deals for both sides, looks forward to presenting alongside some of the industry’s best mediators and sharing the power of technology in mediation. Learn more about Mediation Northwest by visiting mediationnorthwest.com.

ABOUT MEDIATION NORTHWEST

Mediation Northwest is led by attorney Julie Gentili and helps families navigate divorce with the best possible outcomes.

Media Contact
Company Name: Mediation Northwest
Contact Person: Julie Gentili
Email: Send Email
Address:590 Pearl St. Suite #300
City: Eugene
State: Oregon 97401
Country: United States
Website: https://mediationnorthwest.com/

ADMANITY YES! TEST CEO, Brian Gregory Wins 2025 Alignable “Local Business Person Of The Year,” Contest In USA and Canada With Record-Breaking 1st Place Finish, Out Of 9.5+ Million Alignable Members.

ADMANITY YES! TEST CEO, Brian Gregory Wins 2025 Alignable "Local Business Person Of The Year," Contest In USA and Canada With Record-Breaking 1st Place Finish, Out Of 9.5+ Million Alignable Members.

“I am most grateful for all those who voted for me, plus a total of over 700 testimonials received on Alignable and in the 2025 Alignable Local Business Person Of The Year Contest. Alignable is an incredible business platform that offers hundreds of virtual Smart Connect networking events, webinars and live events for its members at a very low cost. I simply took advantage of the great tools they offered to win,” said ADMANITY® and YES! TEST™ CEO, Brian Gregory.
In a landslide victory, ADMANITY® and YES! TEST™ CEO Brian Gregory has won the “Alignable Local Business Person Of The Year Contest” for 2025. The annual contest asks 9.5 million Alignable members to vote freely for those they think should be Local Business Person Of The Year for both Canada and USA. This year, in just 7 weeks, using The YES! TEST™, Brian Gregory broke all previous Alignable contest records with 530 votes, 129 votes more than his nearest competitor winning first place honors.

PHOENIX, ARIZONA, USA and CANADA – “I am most grateful for all those who voted for me, plus a total of over 700 testimonials received on Alignable and in the 2025 Alignable Local Business Person Of The Year Contest. Alignable is an incredible business platform that offers hundreds of virtual Smart Connect networking events, webinars and live events for its members at a very low cost. I simply took advantage of the great tools they offered to win,” said ADMANITY®and YES! TEST™ CEO, Brian Gregory.

Brian Gregory also broke the record for the most votes ever received in the Alignable Local Business Person of the Year Contest during its 6 years of annual competition. To this point, nobody had ever cracked through the 500 vote barrier, which Brian Gregory easily did in 7 weeks with 530 votes. He increased his previous best of 312 votes by 218 votes for a 70% increase in votes over Alignable’s 2024 Local Business Person Of The Year contest.

According to Chuck Casto, Alignable Head of Communications, “Brian’s ascent up the leaderboard this year was nothing short of meteoric, demonstrating his mastery of networking on Alignable—leveraging every tool available to boost his visibility, strengthen relationships, and ultimately attract votes from those he has helped. Through his active participation in both the 2024 and 2025 contests, Smart Connect events, and our new Alignable 360 technology—which uses AI to unlock the full potential of members’ networks, turning them into powerful growth engines—Brian not only secured first place across North America this year, but also tripled the size of his ADMANITY® and YES! TEST™ business.”

When Brian Gregory was asked how he amassed so many votes in such a short time with a relatively small list of connections, Brian Gregory simply said, “I gave the YES! TEST to everyone I met. Every business owner wants to know the marketing answers for their brand for free in 5 minutes.” Brian Gregory created the breakthrough YES! TEST algorithms for his company, ADMANITY®. The YES! TEST is the only business assessment in the world that can reveal the exact emotions necessary for a brand to create more sales, acquire new customers and scale in the marketplace. Astonishingly, the ADMANITY® YES! TEST is given away free at FreeYesTest.com to anyone in business, takes only 5 minutes and delivers dozens of actionable, agency-level marketing recommendations.

“The YES! TEST is a mind-blower because during the entire YES! TEST, it doesn’t ask personal questions about the test-taker or what their business actually does. Business owners already know that. The magic is the YES! TEST figures out exactly how they should present the brand so customers say “YES!” The YES! TEST is the world’s first emotional brand analysis because people always buy on emotion. Business owners that don’t know the emotional formulas for their brand are going to waste a ton of money on marketing, social media, emails, websites, funnels and sales pitches that don’t work,” added Brian Gregory.

Brian Gregory’s company, ADMANITY® doesn’t just provide the YES! TEST™. There is an entire suite of YES-branded products available for businesses to use to increase sales.

For example, YES! QUEST™ for small business lead generation and email marketing systems, YES! PRESS™ and PRESS PAK™ for digital press release syndication and press release page one search engine optimization, YES! MEDIA™ offering over 250 million stock photos and stock videos for instant downloading, YES! BOT™, the world’s most likable AI chat bot, YES! CAPITAL™ for business loans and financing, the YES! REPORT™ with exact branding, advertising, marketing and copywriting solutions after taking the YES! TEST, and all-in-one bundles of B2B business tools such as the YES! PAKPRESS PAK™ and PRO PAK™ for agencies and B2B consultancies. More YES products will emerge in 2025.

“Our YES products are unique and different from anything else on the market, or they are the low-priced alternatives for small businesses needing value-based tools to increase sales and productivity. We help small businesses make more money and get more sales,” said Brian Gregory.

For More information visit:

Brian Gregory on Alignable

ADMANITY®

Video Link: http://player.vimeo.com/video/1067104153

Watch This Video About The YES! TEST™

Media Contact
Company Name: ADMANITY
Contact Person: Brian Gregory
Email: Send Email
City: Phoenix
State: Arizona
Country: United States
Website: https://admanity.com/yes-test/

Plant Growth Regulators Market Size, Share & Trends Analysis: Key Insights from Latest Research

“MarketsandMarkets™”
Plant Growth Regulators Market by Type (Auxins, Cytokinins, Gibberellins, and Ethylene), Function (Plant Growth Promoters, And Plant Growth Inhibitors), Crop Type (Cereals, Oilseeds Fruits, Turfs), By Formulation (Liquid, Granular, Powder, Tablet) and Region – Global Forecast to 2029

The global plant growth regulators market is projected to grow from USD 3.3 billion in 2024 to USD 4.6 billion by 2029, registering a CAGR of 7.2% during the forecast period. The increasing demand for high-value crops is driving the consumption of natural plant growth regulators in agriculture. Additionally, the shift towards sustainable farming practices and the rising adoption of organic farming are further fueling market expansion. Changing dietary preferences and a growing emphasis on sustainable agriculture are also contributing to the increased use of plant growth regulators. These trends underscore the rising significance and widespread adoption of plant growth regulators in modern agriculture.

Plant Growth Regulators Market

 

Plant Growth Regulators Market Trends

The Plant Growth Regulators (PGR) Market is experiencing notable growth due to increasing demand for sustainable agriculture, advancements in biotechnology, and climate change concerns. Here are some of the latest trends shaping the market:

1. Rising Demand for Bio-Based PGRs

  • There is a strong shift toward organic and bio-based plant growth regulators due to consumer preference for eco-friendly and chemical-free products.
  • Companies are investing in microbial-based PGRs such as gibberellins and auxins derived from plant and microbial sources.

2. Precision Agriculture and Smart PGR Application

  • AI-driven farming and precision agriculture are optimizing PGR use to enhance yield efficiency.
  • Drone and sensor-based applications of PGRs are becoming more common to ensure accurate and sustainable usage.

3. Increasing Use of Cytokinins in Horticulture

  • The horticulture sector, including fruits, vegetables, and floriculture, is witnessing higher adoption of cytokinins to enhance flowering and fruit sets.
  • Post-harvest applications of PGRs are helping in extend the shelf life of fresh produce.

4. Growth in the Organic Farming Sector

  • The organic food industry is driving demand for plant-based PGRs as synthetic chemicals face regulatory restrictions.
  • Governments worldwide are offering subsidies and incentives for organic farming, fueling PGR adoption.

5. Regulatory Changes Impacting Synthetic PGRs

  • Stricter environmental and health regulations in Europe and North America are limiting the use of synthetic PGRs like paclobutrazol and daminozide.
  • Manufacturers are reformulating products to comply with sustainable agriculture guidelines.

6. Expansion in Asia-Pacific & Latin America

  • Asia-Pacific is seeing rapid growth due to increased agricultural activities in India, China, and Southeast Asia.
  • Latin America (especially Brazil and Argentina) is witnessing a surge in demand for PGRs in soybean and corn production.

7. Integration with Biostimulants and Fertilizers

  • Companies are launching PGR-fertilizer-biostimulant blends to offer comprehensive crop growth solutions.
  • Synergistic products that combine PGRs with biofertilizers and soil enhancers are gaining traction.

8. Innovations in Plant-Based Hormones

  • Ongoing research in gene editing (CRISPR) and synthetic biology is leading to advanced PGR formulations.
  • Companies are exploring natural hormone mimics that replicate the effects of synthetic regulators.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94580110

Cytokinins Hold the Largest Market Share by Type

Among various plant growth regulators, cytokinins dominate the market, holding the largest share in the type of segment. Cytokinins play a crucial role in cell division, shoot growth, and overall plant development. They stimulate cell enlargement and differentiation, leading to improved crop yield and quality. These hormones are extensively used in fruit and vegetable production to enhance plant vigor, increase flower and fruit sets, and delay senescence. The growing demand for high-yield crops, coupled with advancements in biotechnology and research, has led to the development of innovative cytokinin formulations, further strengthening their market dominance.

Plant Growth Inhibitors to Register the Highest CAGR

In the function segment, the plant growth inhibitors category is expected to grow at the highest CAGR during the forecast period. Farmers and growers are increasingly recognizing the benefits of plant growth inhibitors in regulating plant growth and development. Compounds such as abscisic acid play a vital role in inducing dormancy and abscission, helping manage excessive growth while enhancing stress tolerance in plants. The growing prevalence of abiotic stressors such as drought, salinity, and extreme temperatures has accelerated the adoption of plant growth inhibitors to mitigate their negative impact on crop yield. Additionally, continuous R&D advancements have resulted in the development of more efficient and cost-effective inhibitors, further driving market expansion.

Asia-Pacific dominates the Plant Growth Regulators Market Share.

The Asia-Pacific region holds the largest market share in the plant growth regulators market, driven by several key factors. The region has a highly significant agricultural industry, accounting for a substantial share of global agricultural output. With rising food demand due to population growth and changing dietary preferences, countries in Asia-Pacific are increasingly adopting plant growth regulators to enhance productivity. Furthermore, rapid technological advancements and the adoption of modern agricultural practices—including precision farming—are further boosting market growth. Supportive government initiatives, agricultural investments, and favorable policies are also playing a crucial role in the expansion of the plant growth regulator market in this region.

Leading Plant Growth Regulators Companies:

  • BASF SE (Germany)
  • Corteva Agriscience (US)
  • Syngenta Group (Switzerland)
  • FMC Corporation (US)
  • Nufarm (Australia)
  • Bayer AG (Germany)
  • Tata Chemicals Ltd. (India)
  • UPL (India)
  • Sumitomo Chemical Co. Ltd. (Japan)
  • Nippon Soda Co. Ltd. (Japan)

 

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94580110

BASF SE (Germany)

BASF SE Group operates globally with 234 production sites, including six Verbund sites, and relies on approximately 112,000 employees worldwide. Its operations encompass diverse segments such as chemicals, materials, industrial solutions, surface technologies, nutrition & care, and agricultural solutions. Offering a wide array of system solutions and services, BASF SE caters to industries ranging from chemicals, automotive, and building to agriculture, oil, plastics, electrical, electronics, furniture, and paper. Within its Agricultural Solutions division, BASF SE specializes in providing plant growth regulators. These products target the hormonal system of plants, adjusting the proportions of various plant hormones to facilitate advantageous growth. With a focus on enhancing crop health and yield, BASF SE’s plant growth regulators business segment is involved in researching, developing, manufacturing, and marketing these products.

Corteva Agriscience (US)

Originally part of DowDuPont, Corteva Agriscience emerged as an independent entity following its spinoff, drawing from the esteemed legacies of Dow, DuPont, and Pioneer. Established in 2019, Corteva operates globally, spanning over 140 countries across North America, Latin America, Europe, Australia, Africa, and Asia Pacific. With a core commitment to agriculture and food provision, Corteva specializes in two primary product segments: seeds and crop protection. Its Seed division focuses on developing and delivering advanced germplasm and traits to enhance farm yields, while the Crop Protection segment addresses agricultural challenges by offering weed, insect, pest, and disease control solutions. Among its crop protection offerings are plant growth regulators, herbicides, and insecticides. Additionally, Corteva provides digital service solutions to support farmers in optimizing their agricultural practices.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=94580110

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipelines and win more deals with precision.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/plant-growth-regulators-market-94580110.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Plant Growth Regulators Market Size, Share & Trends Analysis: Key Insights from Latest Research

ZouZou Coffee Launches Groundbreaking Turkish Coffee Machine on Kickstarter

ZouZou Coffee Pty Ltd proudly announces the launch of its innovative stainless-steel, automatic Turkish coffee machine on Kickstarter. Bridging centuries of tradition with modern technology, this pioneering device simplifies the art of stovetop Turkish coffee—delivering from 1 to 10 cups in just 3 to 6 minutes—while preserving the coffee’s signature crema, aroma, and deep flavor.

Filling a Global Gap in Coffee Culture

Founder Joseph Atallah (BSc, Grad Dip Food Science) embarked on this journey upon realizing a staggering market gap. He says, “We started this because there are no stainless-steel Turkish coffee machines in restaurants, mosques, or domestic kitchens. It’s impossible to count the number of espresso machines around the world, yet only ZouZou Coffee truly replicates the stovetop Turkish coffee method.”

Although the coffee-drinking world is roughly split between espresso and Turkish coffee enthusiasts, Turkish coffee had never received a high-tech, automated treatment—until now. Historically, Turkish coffee was the only way of making coffee before Viennese inventors in the 1890s filtered the grind and added whipped cream, paving the way for cappuccinos in the early 1900s. By contrast, ZouZou Coffee preserves this age-old method, updating it with modern engineering and convenience.

Three Distinct Modes: A Modern Take on an Age-Old Ritual

1. Mode [A] – Perfect Crema at 98°C

At exactly 98°C, coffee reaches the peak of its crema formation. Mode [A] automatically pauses at this critical juncture to avoid over-extraction, ensuring the thick, frothy layer that Turkish coffee drinkers cherish.

2. Mode [M] – Multiple Boils, Enhanced Flavor

Inspired by the traditional belief that repeated boiling intensifies flavor, Mode [M] allows the brew to reach a rolling boil multiple times—without boiling over. By precisely balancing time, temperature, and heat, ZouZou Coffee ensures optimal extraction of the coffee’s deepest notes.

3. Mode [R] – Quick Rinse for Impeccable Cleanliness

Mode [R] automatically flushes away coffee grounds and residue from the machine’s internal components. This fast, efficient rinse helps preserve taste integrity while keeping the machine in top condition.

Bringing Turkish Coffee into the Modern Era

  • Tradition Meets Technology: Turkish coffee is one of the oldest brewing methods in the world, predating espresso by centuries. Yet in today’s busy world, many find it cumbersome to monitor stovetop pots or risk boil-overs. ZouZou Coffee’s machine replicates these traditional stovetop nuances in a fully automated, user-friendly system that can be placed in any setting—restaurants, mosques, cafés, or domestic kitchens—where electricity is available.

  • Quality Engineering, Globally Accessible: Designed with adaptability in mind, the ZouZou Coffee machine can be fabricated and assembled in different regions around the globe. Precision engineering ensures consistent results cup after cup, without demanding years of practice or constant vigilance.

  • Reviving Cultural Heritage: Beyond convenience, ZouZou Coffee preserves cultural customs like coffee cup reading, a cherished ritual in many communities. By retaining the coffee grounds just as in stovetop brewing, ZouZou allows users to enjoy this time-honored tradition without sacrificing modern efficiencies.


Kickstarter is Now Live

ZouZou Coffee invites coffee lovers, distributors, café owners, and restaurateurs to back this pioneering campaign. Funds raised through Kickstarter will help scale production, source premium materials, and bring authentic Turkish coffee to more homes and businesses worldwide.

Join ZouZou Coffee in celebrating the revival of genuine Turkish coffee—modernized, perfected, and ready for the world to enjoy.

To support ZouZou Coffee, visit its official Kickstarter page.

About ZouZou Coffee Pty Ltd

Headquartered in Sydney, New South Wales, Australia, ZouZou Coffee Pty Ltd specializes in enhancing classic coffee-making traditions with inventive design, cutting-edge technology, and unwavering dedication to authentic taste. Under the leadership of founder and food science specialist Joseph Atallah, ZouZou Coffee seamlessly marries the cherished legacy of Turkish coffee with the convenience of the modern era.

Learn more at: www.zouzoucoffee.com.

Media Contact
Company Name: ZouZou Coffee Pty Ltd
Contact Person: Joseph Atallah (BSc, Grad Dip Food Science)
Email: Send Email
City: Sydney
State: New South Wales
Country: Australia
Website: www.zouzoucoffee.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: ZouZou Coffee Launches Groundbreaking Turkish Coffee Machine on Kickstarter

Electronic Warfare Market worth $19.4 Billion by 2028, at a CAGR of 12.5%

“Electronic Warfare Market”
The Electronic Warfare Market Value is projected to be USD 19.4 billion by 2028, growing from USD 0.8 billion in 2023, at a Compound Annual Growth Rate (CAGR) of 12.5% during the forecast period.

The report “Electronic Warfare Market by Platform (Ground, Naval, Airborne, Space), Capability (Electronic Support, Electronic Attack, Electronic Protection), End-Use, Product (Electronic Warfare Equipment, Operational Support) and Region – Global Forecast to 2028” The Electronic Warfare Industry is valued at USD 10.8 billion in 2023 and is projected to reach USD 19.4 billion by 2028, at a CAGR of 12.5% from 2023 to 2028. Electronic Warfare (EW) encompasses the capability to utilize the electromagnetic spectrum-including signals like radio, infrared, or radar-for sensing, protection, and communication purposes. Simultaneously, EW has the capacity to disrupt, deny, and degrade the adversaries’ utilization of these signals. Electronic Warfare (EW) serves as a vital tool for managing the electromagnetic (EM) spectrum, enabling the detection, analysis, and tracking of potential threats. This enables countries and their allies with essential situational awareness necessary for preemptive defensive measures, diplomatic insights, and offensive strategies across all levels, even prior to conflicts emerging. EW facilitates Joint Electromagnetic Spectrum Operations (JEMSO), empowering armed forces to exploit, attack, and safeguard the EM operational environment.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1301

Browse 417 market data Tables and 85 Figures spread through 393 Pages and in-depth TOC on “Electronic Warfare Market by Platform (Ground, Naval, Airborne, Space), Capability (Electronic Support, Electronic Attack, Electronic Protection), End-Use, Product (Electronic Warfare Equipment, Operational Support) and Region – Global Forecast to 2028”

View detailed Table of Content herehttps://www.marketsandmarkets.com/Market-Reports/electronic-warfare-market-1301.html

Key drivers include geopolitical tensions, technological advancements, and increased electronic threats. Leading players like BAE Systems (UK), Raytheon Technologies Corporation (US), Northrop Grumman (US), L3Harris Technologies, Inc. (US), Lockheed Martin Corporation (US), Israel Aerospace Industries (Israel), Elbit Systems (UK) develop advanced EW solutions leveraging sensor technology and cyber defense expertise to meet military and government needs. The main developers and users of active Electronic Warfare (EW) systems and equipment comprise a diverse group of nations, including the United States, United Kingdom, Canada, China, Russia, Israel, India, Japan, North Korea, France, Germany, and Sweden. These countries leverage a wide array of EW technologies and intelligence-gathering services to bolster their defense capabilities. Additionally, numerous other nations around the globe utilize EW technologies and services through allied security agreements, further enhancing their security posture and operational effectiveness

Electronic Warfare Industry Segmentation

Based on the platform, the space segment for electronic warfare industry by platform is estimated to have the highest CAGR in 2023.

Based on the platform, the space segment is estimated to lead the electronic warfare industry from 2023 to 2028. The space platform is experiencing significant growth in the electronic warfare market due to several factors. Firstly, the heightened reliance on satellite communications and navigation systems has made space-based assets vulnerable to electronic threats, driving the need for space-based electronc warfare capabilities. Technological advancements have facilitated the development of sophisticated systems capable of detecting and countering these threats effectively. Moreover, the proliferation of space-based sensors and satellites has increased the demand for electronic warfare solutions to safeguard these assets. As space becomes more crowded and contested, governments and defense organizations are investing in space-based electronic warfare to protect their interests. Additionally, the commercialization of space has led to increased investment in electronic warfare capabilities by companies and organizations operating in space. Overall, these factors contribute to the rapid growth of the space platform in the electronic warfare market.

Based on the end-use, OEMs segment for Electronic Warfare Industry is estimated to have the highest CAGR in 2023.

In 2023, the OEMs segment is anticipated to dominate the Electronic Warfare industry, with highest CAGR. The Original Equipment Manufacturers (OEMs) segment is poised for dominance in the electronic warfare market due to several key factors. OEMs play a pivotal role in designing and producing advanced electronic warfare systems, leveraging their expertise to meet the demands of military and defense customers worldwide. With established relationships and a reputation for delivering comprehensive solutions, including maintenance and support services, OEMs have a competitive edge in securing lucrative contracts. Additionally, their commitment to innovation ensures they remain at the forefront of the market, driving further growth and solidifying their position as leaders in electronic warfare technology.

Based on the capability, the electronic attacks segment for electronic warfare industry is estimated to have the highest CAGR in 2023.

The electronic attack segment is further sub-segmented into active and passive. This dominance is attributed to several key factors. Firstly, electronic attack capabilities are essential for disrupting and neutralizing adversary communication and radar systems, making them indispensable in modern warfare scenarios. Secondly, advancements in technology have enhanced the effectiveness and versatility of electronic attack systems, enabling them to counter increasingly sophisticated threats. Additionally, rising geopolitical tensions and the proliferation of electronic warfare capabilities among both state and non-state actors are driving the demand for robust electronic attack solutions. Overall, these factors position the electronic attack segment for substantial growth and dominance in the EW market.

Geographical Analysis of Electronic Warfare Industry

Based on regions, the Middle East market for Electronic Warfare Industry is estimated to have the highest CAGR during 2023.

The Middle East region is expected to have the highest market share in the Electronic Warfare industry in 2023. Firstly, the region’s geopolitical landscape is characterized by ongoing conflicts and tensions, driving the demand for advanced defense technologies, including EW systems. Secondly, governments in the Middle East are heavily investing in military modernization and technological advancements to enhance their defense capabilities, particularly in response to evolving threats in the region. Additionally, the increasing adoption of EW systems across various defense sectors, including land, air, and naval forces, further fuels market growth. Overall, these factors position the Middle East region as a key driver of growth and dominance in the EW market.

Key Players

Prominent Players in the Electronic Warfare Companies BAE Systems (UK), Raytheon Technologies Corporation (US), Northrop Grumman (US), L3Harris Technologies, Inc. (US), Lockheed Martin Corporation (US), Israel Aerospace Industries (Israel), Elbit Systems (UK). These industry leaders, headquartered in various countries, drive innovation and excellence in electronic warfare globally.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Delray Beach
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/electronic-warfare-market-1301.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Electronic Warfare Market worth $19.4 Billion by 2028, at a CAGR of 12.5%

Dr. Michele Leno Honored with the President’s Lifetime Achievement Award

Detroit, Mich. – March 19th, 2025 – Dr. Michele Leno, a renowned licensed psychologist and media personality, has been awarded the President’s Lifetime Achievement Award for her outstanding commitment to volunteer service. This honor, signed by President Joseph R. Biden Jr., acknowledges Dr. Michele’s 4,000 hours of service are dedicated to empowering individuals and strengthening communities.

A native of Detroit, Dr. Michele has indelibly impacted the mental health field. Through her company, DML Psychological Services, PLLC, she has provided expert psychological evaluations, therapy, coaching, and consulting services across Macomb, Oakland, and Wayne Counties. Additionally, as the host of “Mind Matters with Dr. Michele,” she continues to elevate conversations around mental wellness and personal growth.

Dr. Michele’s expertise has been featured in leading media outlets, including Psychology Today, Insider, Cosmopolitan, and WBRC Fox 6 News. Her dedication to mental health advocacy extends across diverse populations, working with children, adults, athletes, and professionals to encourage personal development.

“I pursued my career determined to make a difference. I focus on inspiring and being inspired,” says Dr. Michele. “Receiving such recognition for something that I absolutely love doing is the ultimate win.”

This recognition emphasizes Dr. Michele’s lifelong mission to promote mental health awareness and provide the tools necessary for individuals to thrive. As she continues to expand her reach through media and professional consulting, her commitment to community well-being remains determined.

About Dr. Michele Leno

Dr. Michele is a native of Detroit and a licensed psychologist in Michigan. She completed her undergraduate studies at Marygrove College, later attended the Michigan School of Professional Psychology, and obtained her M.A. in clinical psychology. She completed her doctoral degree at Saybrook University in California. Dr. Michele owns DML Psychological Services, PLLC, and her company provides consulting services throughout Macomb, Oakland, and Wayne Counties. She is currently hosting the TV talk show “Mind Matters with Dr. Michele” on CW50. Dr. Michele has several years of experience providing individuals and organizations with psychological evaluations, therapy, coaching, and consulting services. She has worked with clients of all ages and backgrounds, including children, adolescents, adults, athletes, and various professionals.

Media Contact
Company Name: Otter Public Relations
Contact Person: Anna Kate Womack
Email: Send Email
Phone: 7032323140
City: ORLANDO
State: FL
Country: United States
Website: www.otterpr.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Dr. Michele Leno Honored with the President’s Lifetime Achievement Award

Metastatic Liver Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND

DelveInsight’s, “Metastatic Liver Cancer Pipeline Insight” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Metastatic-Liver-Cancer pipeline landscape. It covers the Metastatic Liver Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Liver Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Stay ahead with the latest insights! Download DelveInsight’s comprehensive Metastatic Liver Cancer Pipeline Report to explore emerging therapies, key Metastatic Liver Cancer Companies, and future Metastatic Liver Cancer treatment landscapes @ Metastatic Liver Cancer Pipeline Outlook Report

Key Takeaways from the Metastatic Liver Cancer Pipeline Report

  • In March 2025, Akeso announced a phase II Study to Evaluate the Efficacy and Safety of AK104 Plus Lenvatinib and TACE in the Treatment of Unresectable, Non-metastatic Hepatocellular Carcinoma.
  • In March 2025, BeiGene conducted a study was to assess the preliminary antitumor activity as indicated by overall response rate (ORR) of tislelizumab in combination with lenvatinib in participants with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC) by central site imaging facility per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1.
  • In February 2025:- Alethia Biotherapeutics:- This Phase II study will recruit 17 colorectal cancerpatients with liver-dominant metastases. All recruited patients will receive Sotevtamab at a dose of 800 mg once weekly for 6 cycles combined with FOLFOX once every 2 weeks for the first 4 cycles followed by liver metastases resection surgery with or without primary cancer resection. One cycle of treatment will consist of 14 days (2 weeks).
  • In February 2025:- Medivir:- This is an open-label, multicentre dose escalation/expansion study to assess safety and tolerability of MIV 818 as either monotherapy or in combination with 1) lenvatinib, a tyrosine kinase inhibitor used as a standard of care for the treatment of HCC or 2) pembrolizumab, a PD-1 inhibitor. The monotherapy parts of the study will include patients with various solid tumours that have spread to the liver, or alternatively originating in the liver. Evaluations of MIV-818 in combination with lenvatinib or pembrolizumab will only include patients with HCC.
  • In February 2025:- Kamya Sankar:-This clinical trial aims to assess whether the addition of bevacizumab to atezolizumab and chemotherapy can improve response to treatment and progression-free survival in patients with extensive-stage small cell lung cancer (ES-SCLC) with liver metastases.
  • In February 2025:- Tango Therapeutics Inc.:- This is a first in human study in patients with advanced or metastatic solid tumors known to have an MTAP deletion. The first part of the study is an open-label, dose escalation and the second part is an open label dose expansion in specific MTAP-deleted tumor types. The study drug, TNG462, is a selective PRMT5 inhibitor administered orally. The study is planned to treat up to 225 participants.
  • In February 2025:- Bristol-Myers Squibb:- The purpose of this study is to evaluate the safety and effectiveness of triplet therapy of nivolumab, relatlimab and bevacizumab versus nivolumab and bevacizumab in participants with untreated advanced/metastatic hepatocellular carcinoma (HCC).
  • DelveInsight’s Metastatic Liver Cancer pipeline report depicts a robust space with 20+ active players working to develop 25+ pipeline therapies for Metastatic Liver Cancer treatment.
  • The leading Metastatic Liver Cancer Companies such as Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics, Inc., RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeutics, Boehringer Ingelheim, and others.
  • Promising Metastatic Liver Cancer Therapies such as ThermoDox® (LTLD), NV1020, Combretastatin A1 Diphosphate (OXi4503), Talaporfin sodium (LS11), CRS-100, EndoTAG®-1, AV-299, RO7119929, Tocilizumab, and others.

Discover how the Metastatic Liver Cancer treatment paradigm is evolving. Access DelveInsight’s in-depth Metastatic Liver Cancer Pipeline Analysis for a closer look at promising breakthroughs @ Metastatic Liver Cancer Clinical Trials and Studies

Metastatic Liver Cancer Emerging Drugs Profile

  • exoASO STAT6: Codiak BioSciences

exoASO™-STAT6 is an exosome therapeutic candidate engineered using our engEx™ Platform to overexpress Codiak’s novel protein scaffold, PTGFRN, to selectively target uptake in M2 polarized tumor-associated macrophages. Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.

  • STP 705: Sirnaomics

STP705, is a dual TGF-ß1/COX-2 inhibitor. TGF-ß1 and COX-2 are well-validated gatekeeper targets for oncology and fibrosis disease drug development. STP705 leverages our locally administered PNP formulation for direct administration to diseased tissue. STP705 has received U.S. orphan drug designation for the treatment of certain hepatocellular carcinomas and liver fibrosis, including: primary sclerosing cholangitis (PSC), cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC). Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.

  • ONCR 177: Oncorus

ONCR-177, our lead product candidate, is an intratumorally administered Herpes Simplex Virus (HSV) viral immunotherapy for the treatment of multiple solid tumor cancers. ONCR-177 fights tumors through multiple mechanisms, including inherent oncolytic activity, immune stimulation elicited by viral infection and the expression of five transgenes (IL-12, CCL4, FLT3LG, anti-PD-1 and anti-CTLA-4). Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.

The Metastatic Liver Cancer pipeline report provides insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Metastatic Liver Cancer with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Metastatic Liver Cancer Treatment.
  • Metastatic Liver Cancer Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Metastatic Liver Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Metastatic Liver Cancer market.

Get a detailed analysis of the latest innovations in the Metastatic Liver Cancer pipeline. Explore DelveInsight’s expert-driven report today! @ Metastatic Liver Cancer Unmet Needs

Metastatic Liver Cancer Companies

Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics, Inc., RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeutics, Boehringer Ingelheim, and others.

Metastatic-Liver-Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Intra-articular
  • Intraocular
  • Intrathecal
  • Intravenous
  • Ophthalmic
  • Oral
  • Parenteral
  • Subcutaneous
  • Topical
  • Transdermal

Metastatic Liver Cancer Products have been categorized under various Molecule types such as

  • Oligonucleotide
  • Peptide
  • Small molecule

Download DelveInsight’s latest report to gain strategic insights into upcoming Metastatic Liver Cancer Therapies and key Metastatic Liver Cancer Developments @ Metastatic Liver Cancer Market Drivers and Barriers, and Future Perspectives

Scope of the Metastatic Liver Cancer Pipeline Report

  • Coverage- Global
  • Metastatic Liver Cancer Companies- Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics, Inc., RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeutics, Boehringer Ingelheim, and others.
  • Metastatic Liver Cancer Therapies- ThermoDox® (LTLD), NV1020, Combretastatin A1 Diphosphate (OXi4503), Talaporfin sodium (LS11), CRS-100, EndoTAG®-1, AV-299, RO7119929, Tocilizumab, and others.
  • Metastatic Liver Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Metastatic Liver Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Which companies are leading the race in Metastatic Liver Cancer drug development? Find out in DelveInsight’s exclusive Metastatic Liver Cancer Pipeline Report—access it now! @ Metastatic Liver Cancer Emerging Drugs and Major Companies

Table of Content

  1. Introduction
  2. Executive Summary
  3. Metastatic-Liver-Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Metastatic-Liver-Cancer– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Drug name :Company Name
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. Drug name :Company Name
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. ONCR 177: Oncorus
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug name :Company Name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Metastatic-Liver-Cancer Key Companies
  21. Metastatic-Liver-Cancer Key Products
  22. Metastatic-Liver-Cancer- Unmet Needs
  23. Metastatic-Liver-Cancer- Market Drivers and Barriers
  24. Metastatic-Liver-Cancer- Future Perspectives and Conclusion
  25. Metastatic-Liver-Cancer Analyst Views
  26. Metastatic-Liver-Cancer Key Companies
  27. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/medical-marijuana-market-insight

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Metastatic Liver Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND